Deep-learned time-signal intensity pattern analysis using an autoencoder captures magnetic resonance perfusion heterogeneity for brain tumor differentiation
暂无分享,去创建一个
Ilah Shin | Ji Eun Park | Ho Sung Kim | Junkyu Lee | E.-Nae Cheong | Sung Soo Ahn | Woo Hyun Shim | W. Shim | H. Kim | J. E. Park | I. Shin | Junkyu Lee | E. Cheong | S. Ahn
[1] H R Jäger,et al. Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice , 2018, European Radiology.
[2] R. Frayne,et al. Signal‐to‐noise ratio effects in quantitative cerebral perfusion using dynamic susceptibility contrast agents , 2003, Magnetic resonance in medicine.
[3] J. Boxerman,et al. Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object , 2018, American Journal of Neuroradiology.
[4] S. Kralik,et al. Contrast Leakage Patterns from Dynamic Susceptibility Contrast Perfusion MRI in the Grading of Primary Pediatric Brain Tumors , 2016, American Journal of Neuroradiology.
[5] A Gregory Sorensen,et al. Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial. , 2015, Neuro-oncology.
[6] Shing-Tung Yau,et al. Geometric Understanding of Deep Learning , 2018, ArXiv.
[7] Toshiaki Taoka,et al. Application of histogram analysis for the evaluation of vascular permeability in glioma by the K2 parameter obtained with the dynamic susceptibility contrast method: Comparisons with Ktrans obtained with the dynamic contrast enhance method and cerebral blood volume. , 2016, Magnetic resonance imaging.
[8] E. Neuwelt,et al. Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches. , 2006, Neurosurgical focus.
[9] Klaus H. Maier-Hein,et al. The Medical Imaging Interaction Toolkit: challenges and advances , 2013, International Journal of Computer Assisted Radiology and Surgery.
[10] E F Halpern,et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.
[11] J. Titano,et al. Machine learning for semi-automated classification of glioblastoma, brain metastasis and central nervous system lymphoma using magnetic resonance advanced imaging. , 2019, Annals of translational medicine.
[12] S. Park,et al. Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction. , 2018, Radiology.
[13] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[14] J. Boxerman,et al. Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial , 2019, American Journal of Neuroradiology.
[15] Bainan Xu,et al. The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis , 2017, PloS one.
[16] K. Schmainda,et al. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. , 2008, Radiology.
[17] T. Cloughesy,et al. NIMG-24HIGH SPATIOTEMPORAL DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) PERFUSION MRI USING MULTIBAND ECHOPLANAR IMAGING (MB-EPI) , 2015 .
[18] Bradley J. Erickson,et al. Dynamic Susceptibility Contrast-MRI Quantification Software Tool: Development and Evaluation , 2016, Tomography.
[19] B. Jeong,et al. Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network. , 2019, Neuro-oncology.
[20] Vijayan N. Nair,et al. A REVIEW AND RECENT DEVELOPMENTS , 2005 .
[21] Jorge Cadima,et al. Principal component analysis: a review and recent developments , 2016, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[22] R M Weisskoff,et al. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. , 2006, AJNR. American journal of neuroradiology.
[23] Marion Smits,et al. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. , 2015, Neuro-oncology.
[24] Luke Macyszyn,et al. Pattern analysis of dynamic susceptibility contrast-enhanced MR imaging demonstrates peritumoral tissue heterogeneity. , 2014, Radiology.
[25] J. Boxerman,et al. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma , 2019, American Journal of Neuroradiology.
[26] Y. Sung,et al. Detection of Local Recurrence in Patients with Head and Neck Squamous Cell Carcinoma Using Voxel-Based Color Maps of Initial and Final Area under the Curve Values Derived from DCE-MRI , 2019, American Journal of Neuroradiology.
[27] J. Boxerman,et al. The Effect of Pulse Sequence Parameters and Contrast Agent Dose on Percentage Signal Recovery in DSC-MRI: Implications for Clinical Applications , 2013, American Journal of Neuroradiology.
[28] Marc'Aurelio Ranzato,et al. Unsupervised Learning of Invariant Feature Hierarchies with Applications to Object Recognition , 2007, 2007 IEEE Conference on Computer Vision and Pattern Recognition.
[29] Namkug Kim,et al. Radiomic features and multilayer perceptron network classifier: a robust MRI classification strategy for distinguishing glioblastoma from primary central nervous system lymphoma , 2019, Scientific Reports.
[30] J. Boxerman,et al. Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas , 2017, American Journal of Neuroradiology.
[31] Paolo Vitali,et al. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images. , 2018, Radiology.
[32] J. Boxerman,et al. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low–Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors , 2019, American Journal of Neuroradiology.
[33] Christos Davatzikos,et al. In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The ϕ-Index , 2017, Clinical Cancer Research.
[34] Geoffrey E. Hinton,et al. Reducing the Dimensionality of Data with Neural Networks , 2006, Science.
[35] A. Bjørnerud,et al. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma , 2018, American Journal of Neuroradiology.
[36] G. Parker,et al. Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome , 2014, Clinical Cancer Research.
[37] A. Espeland,et al. Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging , 2011, American Journal of Neuroradiology.
[38] Bradley J Erickson,et al. Variability and accuracy of different software packages for dynamic susceptibility contrast magnetic resonance imaging for distinguishing glioblastoma progression from pseudoprogression , 2015, Journal of medical imaging.
[39] M. Berger,et al. Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2007, American Journal of Neuroradiology.